← Back to Search

CHIMES Intervention for Human Immunodeficiency Virus Infection (CHIMES Trial)

N/A
Waitlist Available
Led By Sophia Hussen, MD, MPH
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (months 1-12) up to month 33
Awards & highlights

CHIMES Trial Summary

This trial will test an intervention to improve YB-GBMSM's engagement in HIV and mental health care at Ryan White clinics.

Who is the study for?
This trial is for young Black gay, bisexual, and other men who have sex with men (YB-GBMSM) living with HIV. Participants must be patients at Grady Health System Infectious Disease Program or Emory University Hospital Midtown Infectious Disease Clinic.Check my eligibility
What is being tested?
The study is testing a new support intervention called CHIMES against the standard care provided in clinics. The goal is to improve how these young men engage with their HIV and mental health treatments.See study design
What are the potential side effects?
Since this trial focuses on a support intervention rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological responses to the intervention.

CHIMES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (months 1-12) up to month 33
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (months 1-12) up to month 33 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Mental Health Care Referrals
Number of Mental Health Visits
Number of Patients Attending Two HIV Care Visits
+3 more

CHIMES Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Clinic Patients During the Maintenance PeriodExperimental Treatment1 Intervention
Patients visiting one of the study clinics during the Maintenance period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 28 - 33.
Group II: Clinic Patients During the Implementation PeriodExperimental Treatment1 Intervention
Patients visiting one of the study clinics during the Implementation period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 13 - 27.
Group III: Clinic Patients During the Pre-implementation PeriodActive Control1 Intervention
Patients visiting one of the study clinics prior to implementation of the CHIMES intervention. The Baseline time period consists of study Months 1 - 12. Data are retroactively abstracted from medical records of patients who had clinic visits that occurred between January 1, 2019 and December 31, 2019.

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,798 Previous Clinical Trials
2,660,068 Total Patients Enrolled
Emory UniversityLead Sponsor
1,645 Previous Clinical Trials
2,563,700 Total Patients Enrolled
Sophia Hussen, MD, MPHPrincipal InvestigatorEmory University

Media Library

Standard of Care Clinical Trial Eligibility Overview. Trial Name: NCT04833829 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Clinic Patients During the Maintenance Period, Clinic Patients During the Implementation Period, Clinic Patients During the Pre-implementation Period
Human Immunodeficiency Virus Infection Clinical Trial 2023: Standard of Care Highlights & Side Effects. Trial Name: NCT04833829 — N/A
Standard of Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04833829 — N/A
~0 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top